Visit-to-visit variability is relatively consistently linked to AD biomarkers across different patient populations [12, 28, 29, 31], whereas shorter-term BPV (i.e., day-to-day or 24-h) generally did not relate to tau or Aβ in previous studies [15, 16], including this current report. Here, MAPT is linked to Alzheimer disease.